Macrophages are key cells of the innate immune response against infections, but their roles in allergy and other type 2 inflammatory diseases are poorly understood. With her research team, Julia Esser-von Bieren wants to shed new light on how macrophages are reprogrammed during allergic inflammation. In the recent competitive call for Helmholtz Young Investigator (HYI) groups, Julia Esser-von Bieren’s proposal was selected as one of the 15 new research groups that will be funded during a six year period. The HYI funding will allow Esser-von Bieren’s team to perform cutting edge research on “Macrophage reprogramming in type 2 inflammation”. By exploring mechanisms behind the pro-inflammatory roles of macrophages and developing new strategies to reprogram these cells, the HYI group aims to innovate the therapy of allergy and related diseases.
New Helmholtz Young Investigator group “Innate Immunomodulation” at IAF
Prof. Dr. rer. nat. Carsten B. Schmidt-Weber
Chair for Molecular Allergology (Klinikum rechts der Isar)
Director of the Institute of Allergy research (IAF; Helmholtz Zentrum München)